Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to attend the following events in May 2019:


Conference details:

5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit

Date: Wednesday, May 8, 2019

Location: New York, NY

 

CAR-T and The Rise of the Cellicon Valley

Date: Friday, May 10, 2019

Presentation Time: 3:30 p.m.  EDT         

Location: Philadelphia, PA

 

Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum

Date: Friday, May 31, 2019

Presentation Time: 11:50 a.m. EDT

Location: Chicago, IL

***END***

Download press release(s)

Press release

96.22 Ko

Communiqué de presse

108.85 Ko

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Next News

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights